SCI & TECH● LOWAug 14 · Aug 14, 2026, 12:28 AM
CapsoVision anticipates FDA clearance for AI Highlights by end of Q3 as it targets Q4 CapsoCam Colon submission
Seeking Alpha Tech
CapsoVision expects FDA clearance for its AI Highlights technology by the end of Q3 and plans to submit CapsoCam Colon for approval in Q4. This indicates progress in the development and regulatory pathway for new medical imaging technologies.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Sci & Tech
SCI & TECH1h agoChina trial shows gum tissue stem cells help 55% of lifetime diabetes patientsSouth China Morning PostSCI & TECH1h agoSRM presents The Hindu Semiconductor Summit 2026 | Watch LIVEThe HinduSCI & TECH2h agoAnthropic files for potentially the biggest IPO ever as CEO warns of risk to humanity from AIthedailytimes.com · United StatesSCI & TECH2h agoApple responds to early screen flaws on $1,999 foldable iPhone DuoSeeking Alpha Tech